Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: Potential regulation by ligand-dependent degradation and HIF-1α
- 26 May 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 346 (1) , 252-258
- https://doi.org/10.1016/j.bbrc.2006.05.110
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2005
- Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4Cancer Research, 2004
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- Quantitative mRNA Expression Analysis from Formalin-Fixed, Paraffin-Embedded Tissues Using 5′ Nuclease Quantitative Reverse Transcription-Polymerase Chain ReactionThe Journal of Molecular Diagnostics, 2000
- ChemokinesImmunity, 2000
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999
- Phorbol Esters and SDF-1 Induce Rapid Endocytosis and Down Modulation of the Chemokine Receptor CXCR4The Journal of cell biology, 1997
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodiesAPMIS, 1995
- Comparison of Estrogen Receptor Levels in Primary and Regional Metastatic Carcinoma of the BreastAnnals of Surgery, 1979